Ticker
NAGECompany Name
NIAGEN BIOSCIENCE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
---|---|---|---|
6/30/2025 | $ 692.5M | 33.05 | $ 20.95M |
3/31/2025 | $ 613.51M | 31.36 | $ 19.56M |
12/31/2024 | $ 393.39M | 32.88 | $ 11.97M |
9/30/2024 | $ 237.07M | 58.11 | $ 4.08M |
6/30/2024 | $ 174.94M | 179.25 | $ 976K |
3/31/2024 | $ 264.97M | 58.53 | $ 4.53M |
12/31/2023 | $ 106.99M | 15.34 | $ 6.97M |
9/30/2023 | $ 97.22M | 16.63 | $ 5.85M |
6/30/2023 | $ 101.34M | 60.18 | $ 1.68M |
3/31/2023 | $ 91.15M | 0 | $ -5.51M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / FCF
(=) EV/FCF
EV/FCF for NIAGEN BIOSCIENCE INC is calculated as follows: EV [ $ 281.69M ] / FCF [ $ -11.66M ]
(=) EV/FCF [ 0 ]
Minimum
Dec 31, 2023
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 2.2K |
---|---|
min | 0.05 |
max | 77.98 |
average | 23.46 |
median | 19.08 |
std | 16.15 |